{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:53:43Z","timestamp":1770278023473,"version":"3.49.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"suppl_5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11,15]]},"DOI":"10.1093\/cid\/civ595","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T00:33:10Z","timestamp":1447115590000},"page":"S404-S409","source":"Crossref","is-referenced-by-count":18,"title":["Technical Development of a New Meningococcal Conjugate Vaccine"],"prefix":"10.1093","volume":"61","author":[{"given":"Carl E.","family":"Frasch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhash V.","family":"Kapre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Che-Hung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marie","family":"Pr\u00e9aud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,11,9]]},"reference":[{"key":"key\n\t\t\t\t20171014003038_CIV595C1","first-page":"113","article-title":"Meningococcal Meningitis","volume-title":"Vaccines and immunotherapy","year":"1991"},{"key":"key\n\t\t\t\t20171014003038_CIV595C2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/511646","article-title":"Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger","volume":"44","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014003038_CIV595C3","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1086\/507339","article-title":"The rise and fall of epidemic Neisseria meningitidis serogroup W meningitis in Burkina Faso, 2002\u20132005","volume":"43","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014003038_CIV595C4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1128\/CVI.00479-10","article-title":"Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine","volume":"18","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20171014003038_CIV595C5","first-page":"B13","article-title":"Epidemic meningitis due to group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution","volume":"27S","year":"2009","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171014003038_CIV595C6","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1365-3156.2010.02660.x","article-title":"The epidemiology of meningococcal disease in India","volume":"15","year":"2010","journal-title":"Trop Med Int Health"},{"key":"key\n\t\t\t\t20171014003038_CIV595C7","first-page":"1","article-title":"La m\u00e9ningite c\u00e9r\u00e9bro-spinale en Afrique","volume":"28","year":"1963","journal-title":"Bull WHO"},{"key":"key\n\t\t\t\t20171014003038_CIV595C8","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1377\/hlthaff.2011.0328","article-title":"Eliminating epidemic group A meningococcal meningitis in Africa through a new vaccine","volume":"30","year":"2011","journal-title":"Health Aff (Millwood)"},{"key":"key\n\t\t\t\t20171014003038_CIV595C9","first-page":"617","article-title":"Successful intervention in a group A meningococcal outbreak in Auckland, New Zealand","volume":"11","year":"1992","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20171014003038_CIV595C10","first-page":"245","article-title":"Meningococcal vaccines: past, present and future","volume-title":"Meningococcal disease","year":"1995"},{"key":"key\n\t\t\t\t20171014003038_CIV595C11","first-page":"469","article-title":"New and improved vaccines against meningococcal disease","volume-title":"New generation vaccines","year":"1997"},{"key":"key\n\t\t\t\t20171014003038_CIV595C12","first-page":"228","article-title":"Neisseria meningitidis vaccines","volume-title":"Bacterial vaccines","year":"2003"},{"key":"key\n\t\t\t\t20171014003038_CIV595C13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0264-410X(83)90010-5","article-title":"Physiochemical and immunological characterization of meningococcal group A polysaccharide-tetanus toxoid conjugates prepared by two methods","volume":"1","year":"1983","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171014003038_CIV595C14","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.4049\/jimmunol.127.3.1011","article-title":"Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates","volume":"127","year":"1981","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20171014003038_CIV595C15","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1128\/IAI.70.7.3707-3713.2002","article-title":"Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responses","volume":"70","year":"2002","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20171014003038_CIV595C16","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1128\/IAI.41.2.609-617.1983","article-title":"Immunological evaluation of meningococcal group C polysaccharide-tetanus toxoid conjugate in mice","volume":"41","year":"1983","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20171014003038_CIV595C17","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1016\/j.vaccine.2009.06.013","article-title":"Preparation of bacterial polysaccharide-protein conjugates: analytical and manufacturing challenges","volume":"27","year":"2009","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171014003038_CIV595C18","first-page":"A97","article-title":"The Meningitis Vaccine Project","volume":"25S","year":"2007","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171014003038_CIV595C19","first-page":"61058","article-title":"Product development partnerships hit their stride: lessons from developing a meningitis vaccine for Africa.","volume":"30","year":"2011","journal-title":"Health Aff"},{"key":"key\n\t\t\t\t20171014003038_CIV595C20","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/S0140-6736(03)13494-0","article-title":"Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries","volume":"361","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171014003038_CIV595C21","first-page":"37","article-title":"Conjugation: design, chemistry, and analysis","volume-title":"Development and clinical uses of Haemophilus b conjugate vaccines","year":"1994"},{"key":"key\n\t\t\t\t20171014003038_CIV595C22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0264-410X(95)00195-7","article-title":"Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluroborate for use in protein-polysaccharide conjugate vaccines and immunological reagents","volume":"14","year":"1996","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171014003038_CIV595C23","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.vaccine.2008.11.065","article-title":"Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa","volume":"27","year":"2009","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171014003038_CIV595C24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4161\/hv.19619","article-title":"Development of a group A meningococcal conjugate vaccine MenAfriVac","volume":"8","year":"2012","journal-title":"Human Vacc Immunother"},{"key":"key\n\t\t\t\t20171014003038_CIV595C25","article-title":"Polysaccharide-protein conjugate vaccine"},{"key":"key\n\t\t\t\t20171014003038_CIV595C26","article-title":"Physicalchemical and immunological characterization of the drug product (final lot) of a meningococcal group A conjugate vaccine [Abstract P101]","year":"2008"},{"key":"key\n\t\t\t\t20171014003038_CIV595C27","doi-asserted-by":"crossref","first-page":"7261","DOI":"10.1016\/j.vaccine.2007.07.037","article-title":"Characterization and immunogenicity of meningococcal group C conjugate vaccine prepared using hydrazide-activated tetanus toxoid","volume":"25","year":"2007","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171014003038_CIV595C28","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1016\/j.vaccine.2010.05.079","article-title":"Determination of hydrazine in a meningococcal C conjugate vaccine intermediary product","volume":"28","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171014003038_CIV595C29","doi-asserted-by":"crossref","first-page":"7972","DOI":"10.1016\/j.vaccine.2007.06.018","article-title":"Comparison of Neisseria meningitidis serogroup W polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide","volume":"25","year":"2007","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171014003038_CIV595C30","first-page":"A101","article-title":"Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults","volume":"25S","year":"2007","journal-title":"Vaccine"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/61\/suppl_5\/S404\/20914290\/civ595.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T20:09:14Z","timestamp":1692130154000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/61\/suppl_5\/S404\/418221\/Technical-Development-of-a-New-Meningococcal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,9]]},"references-count":30,"journal-issue":{"issue":"suppl_5","published-online":{"date-parts":[[2015,11,9]]},"published-print":{"date-parts":[[2015,11,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/civ595","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,11,15]]},"published":{"date-parts":[[2015,11,9]]}}}